These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10498559)

  • 1. Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial.
    Tasker SA; Treanor JJ; Paxton WB; Wallace MR
    Ann Intern Med; 1999 Sep; 131(6):430-3. PubMed ID: 10498559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study.
    Glesby MJ; Hoover DR; Farzadegan H; Margolick JB; Saah AJ
    J Infect Dis; 1996 Dec; 174(6):1332-6. PubMed ID: 8940228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial.
    Tasker SA; O'Brien WA; Treanor JJ; Weiss PJ; Olson PE; Kaplan AH; Wallace MR
    Vaccine; 1998; 16(9-10):1039-42. PubMed ID: 9682356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of influenza vaccination on disease progression among HIV-infected persons.
    Sullivan PS; Hanson DL; Dworkin MS; Jones JL; Ward JW;
    AIDS; 2000 Dec; 14(17):2781-5. PubMed ID: 11125897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial.
    McKittrick N; Frank I; Jacobson JM; White CJ; Kim D; Kappes R; DiGiorgio C; Kenney T; Boyer J; Tebas P
    Ann Intern Med; 2013 Jan; 158(1):19-26. PubMed ID: 23277897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
    Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A
    AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients.
    Fowke KR; D'Amico R; Chernoff DN; Pottage JC; Benson CA; Sha BE; Kessler HA; Landay AL; Shearer GM
    AIDS; 1997 Jul; 11(8):1013-21. PubMed ID: 9223736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccination of pregnant women and protection of their infants.
    Madhi SA; Cutland CL; Kuwanda L; Weinberg A; Hugo A; Jones S; Adrian PV; van Niekerk N; Treurnicht F; Ortiz JR; Venter M; Violari A; Neuzil KM; Simões EA; Klugman KP; Nunes MC;
    N Engl J Med; 2014 Sep; 371(10):918-31. PubMed ID: 25184864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
    Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of acute influenza infection and Influenza vaccination on HIV viral load and CD4 cell counts.
    Skiest DJ; Machala T
    J Clin Virol; 2003 Apr; 26(3):307-15. PubMed ID: 12637080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
    Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
    Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients.
    Cagigi A; Pensieroso S; Ruffin N; Sammicheli S; Thorstensson R; Pan-Hammarström Q; Hejdeman B; Nilsson A; Chiodi F
    Vaccine; 2013 Apr; 31(18):2231-7. PubMed ID: 23499520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.
    King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB
    J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influenza vaccination of human immunodeficiency virus-infected patients with severe immunodepression. Impact on CD4 lymphocytes and plasma viral load].
    Gutiérrez F; Maestre A; Manuel Ramos J; Masiá M; Escolano C; Hidalgo AM
    Med Clin (Barc); 2001 Oct; 117(11):410-2. PubMed ID: 11602169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users.
    Amendola A; Boschini A; Colzani D; Anselmi G; Oltolina A; Zucconi R; Begnini M; Besana S; Tanzi E; Zanetti AR
    J Med Virol; 2001 Dec; 65(4):644-8. PubMed ID: 11745926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response.
    Fuller JD; Craven DE; Steger KA; Cox N; Heeren TC; Chernoff D
    Clin Infect Dis; 1999 Mar; 28(3):541-7. PubMed ID: 10194075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.
    Günthard HF; Wong JK; Spina CA; Ignacio C; Kwok S; Christopherson C; Hwang J; Haubrich R; Havlir D; Richman DD
    J Infect Dis; 2000 Feb; 181(2):522-31. PubMed ID: 10669335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compromised B cell responses to influenza vaccination in HIV-infected individuals.
    Malaspina A; Moir S; Orsega SM; Vasquez J; Miller NJ; Donoghue ET; Kottilil S; Gezmu M; Follmann D; Vodeiko GM; Levandowski RA; Mican JM; Fauci AS
    J Infect Dis; 2005 May; 191(9):1442-50. PubMed ID: 15809902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals.
    Tebas P; Frank I; Lewis M; Quinn J; Zifchak L; Thomas A; Kenney T; Kappes R; Wagner W; Maffei K; Sullivan K;
    AIDS; 2010 Sep; 24(14):2187-92. PubMed ID: 20616698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of influenza vaccination in individuals infected with HIV.
    Zanetti AR; Amendola A; Besana S; Boschini A; Tanzi E
    Vaccine; 2002 Dec; 20 Suppl 5():B29-32. PubMed ID: 12477415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.